335. ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHÇET'S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL OF EFFICACY AND SAFETY (ALEVIATE). (29th March 2019)

Record Type:: Journal Article
Title:: 335. ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHÇET'S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL OF EFFICACY AND SAFETY (ALEVIATE). (29th March 2019)
Main Title:: 335. ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHÇET'S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL OF EFFICACY AND SAFETY (ALEVIATE)
Authors:: Prasinou, Maria
Smith, Rona
Gopaluni, Seerapani
Jayne, David
Abstract:
Is Part Of:: Rheumatology. Volume 58(2019)Supplement 2
Journal:: Rheumatology
Issue:: Volume 58(2019)Supplement 2
Issue Display:: Volume 58, Issue 2 (2019)
Year:: 2019
Volume:: 58
Issue:: 2
Issue Sort Value:: 2019-0058-0002-0000
Page Start:
Page End:
Publication Date:: 2019-03-29
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/kez063.059 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12039.xml